Monthly Spot-On Flea Treatment for Kittens & Cats up to 4kg

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

INDOXACARB

Available from:

INTERVET AUSTRALIA PTY LIMITED

INN (International Name):

indoxacarb(195g/L)

Pharmaceutical form:

TOPICAL SOLUTION/SUSPENSION

Composition:

INDOXACARB OXADIAZINE Active 195.0 g/L

Units in package:

Pipette; 1x0.51mL; 3x0.51mL; 4x0.51mL; 6x0.51mL

Class:

VP - Veterinary Pesticide

Manufactured by:

INTERVET AUSTRALIA

Therapeutic area:

PARASITICIDES

Product summary:

Poison schedule: 6; Withholding period: ; Host/pest details: CAT - UP TO 4KG: [FLEA ALLERGIC DERMATITIS, FLEA INFESTATIONS]; Controls existing flea infestations and provides control of new infestations for up to 4 weeks. Control of flea allergy dermatitis for up to 4 weeks. Controls immature stages of fleas.DO NOT use on cats under 8 weeks of age. DO NOT allow children to apply the product. DO NOT use on other animals. See CONTRAINDICATIONS on label also.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

MONTHLY SPOT-ON FLEA TREATMENT FOR KITTENS & CATS UP TO 4KG
83293/110216
Product Name:
APVMA Approval No:
Label Name:
MONTHLY SPOT-ON FLEA TREATMENT FOR KITTENS & CATS UP TO 4KG
Signal Headings:
POISON
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
Constituent
Statements:
195 g/L Indoxacarb (S-isomer)
Claims:
INDICATIONS
• Controls existing flea infestations and provides control of new
infestations for up to 4
weeks
• Control of flea allergy dermatitis for up to 4 weeks
• Controls immature stages of fleas
Net Contents:
0.51 mL
1 x 0.51 mL
3 x 0.51 mL
4 x 0.51 mL
6 x 0.51 mL
Directions for Use:
Restraints:
DO NOT use on cats under 8 weeks of age.
DO NOT allow children to apply the product.
DO NOT use on other animals.
Contraindications:
CONTRAINDICATION
Indoxacarb and lidocaine (lignocaine) have the same mode of action,
hence MONTHLY
SPOT-ON FLEA TREATMENT should be used with caution in cats in which
the use of
lidocaine is contraindicated.
Page 1 of 4 RLP APPROVED
Precautions:
Side Effects:
Clinical signs of squinting, head shaking, salivation and scratching
at or rubbing on the site
of product application or the face have occasionally been reported
post treatment. In rare
cases of licking the product, gastrointestinal signs (eg. vomiting) or
reversible neurological
signs (eg. incoordination, tremor) have been observed in cats. These
reactions will be
transient in nature resolving completely.
Dosage and
Administration:
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
FOR EXTERNAL APPLICATION ONLY. READY FOR USE.
DO NOT REMOVE APPLICATOR UNTIL READY TO USE.
READ ACCOMPANYING INSTRUCTIONS BEFORE USE.
DOSAGE AND ADMINISTRATION:
Fleas (Ctenocephalides felis): For the treatment and prevention of
flea infestations for up
to 4 weeks after treatment, apply the entire contents of one
applicator as directed. One
application on the skin lasts for up to 4 weeks. For ongoing flea
control, use the appropriate
MONTHLY SPOT-ON FLEA TREATMENT for Cats for the relev